Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
Ann Oncol
.
2021 Jun;32(6):801-805.
doi: 10.1016/j.annonc.2021.02.014.
Epub 2021 Mar 5.
Authors
A Vogel
1
,
E Martinelli
2
;
ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
;
ESMO Guidelines Committee
Collaborators
A Vogel
,
A Cervantes
,
I Chau
,
B Daniele
,
J M Llovet
,
T Meyer
,
J-C Nault
,
U Neumann
,
J Ricke
,
B Sangro
,
P Schirmacher
,
C Verslype
,
C J Zech
,
D Arnold
,
E Martinelli
Affiliations
1
Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.
2
Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
PMID:
33716105
DOI:
10.1016/j.annonc.2021.02.014
No abstract available
Publication types
Letter
MeSH terms
Carcinoma, Hepatocellular* / epidemiology
Carcinoma, Hepatocellular* / therapy
Humans
Liver Neoplasms* / drug therapy
Liver Neoplasms* / epidemiology